Shots: Ci:z’s acquisition holds two-third of its shares for $52.3/share and ~$2041M as total deal value along with its dermatology products i.e. Dr.Ci:Labo, Labo Labo and Genomer The transaction is expected to enhance and strengthen J&J’s footprints in Japan with its effective dermatology products On 29 Oct, 2018 J&J will announce its tender offer (acquisition […]Read More
